Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 85

1.

Molecular approaches for improved clotting factors for hemophilia.

Kaufman RJ, Powell JS.

Hematology Am Soc Hematol Educ Program. 2013;2013:30-6. doi: 10.1182/asheducation-2013.1.30.

PMID:
24319159
[PubMed - indexed for MEDLINE]
Free Article
2.

Molecular approaches for improved clotting factors for hemophilia.

Kaufman RJ, Powell JS.

Blood. 2013 Nov 21;122(22):3568-74. doi: 10.1182/blood-2013-07-498261. Epub 2013 Sep 24. Review.

PMID:
24065241
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Recombinant factor VIII in the management of hemophilia A: current use and future promise.

Powell JS.

Ther Clin Risk Manag. 2009 Apr;5(2):391-402. Epub 2009 May 20.

PMID:
19536318
[PubMed]
Free PMC Article
4.

Defining the impact of hemophilia: the Academic Achievement in Children with Hemophilia Study.

Shapiro AD, Donfield SM, Lynn HS, Cool VA, Stehbens JA, Hunsberger SL, Tonetta S, Gomperts ED; Academic Achievement in Children with Hemophilia Study Group.

Pediatrics. 2001 Dec;108(6):E105.

PMID:
11731632
[PubMed - indexed for MEDLINE]
5.

The old and new: PCCs, VIIa, and long-lasting clotting factors for hemophilia and other bleeding disorders.

Ragni MV.

Hematology Am Soc Hematol Educ Program. 2013;2013:44-51. doi: 10.1182/asheducation-2013.1.44. Review.

PMID:
24319161
[PubMed - indexed for MEDLINE]
Free Article
6.

Past, present and future of hemophilia: a narrative review.

Franchini M, Mannucci PM.

Orphanet J Rare Dis. 2012 May 2;7:24. doi: 10.1186/1750-1172-7-24. Review.

PMID:
22551339
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The promise and challenges of bioengineered recombinant clotting factors.

Pipe SW.

J Thromb Haemost. 2005 Aug;3(8):1692-701. Review.

PMID:
16102035
[PubMed - indexed for MEDLINE]
8.

Factor VIII half-life and clinical phenotype of severe hemophilia A.

van Dijk K, van der Bom JG, Lenting PJ, de Groot PG, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, van den Berg HM.

Haematologica. 2005 Apr;90(4):494-8.

PMID:
15820945
[PubMed - indexed for MEDLINE]
Free Article
9.

Recent advances in the development of coagulation factors and procoagulants for the treatment of hemophilia.

Schaub RG.

Biochem Pharmacol. 2011 Jul 15;82(2):91-8. doi: 10.1016/j.bcp.2011.03.015. Epub 2011 Mar 29. Review.

PMID:
21453683
[PubMed - indexed for MEDLINE]
10.

Advances in care of children with hemophilia.

Manco-Johnson MJ, Riske B, Kasper CK.

Semin Thromb Hemost. 2003 Dec;29(6):585-94. Review.

PMID:
14719175
[PubMed - indexed for MEDLINE]
11.

Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.

[No authors listed]

CMAJ. 1995 Jul 15;153(2):147-57.

PMID:
7600466
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Hemophilia: new protein therapeutics.

Pipe SW.

Hematology Am Soc Hematol Educ Program. 2010;2010:203-9. doi: 10.1182/asheducation-2010.1.203. Review.

PMID:
21239795
[PubMed - indexed for MEDLINE]
Free Article
13.

New treatments in hemophilia: insights for the clinician.

Knobe K, Berntorp E.

Ther Adv Hematol. 2012 Jun;3(3):165-75. doi: 10.1177/2040620712440007.

PMID:
23556123
[PubMed]
Free PMC Article
14.

New developments in the treatment of pediatric hemophilia and bleeding disorders.

Branchford BR, Monahan PE, Di Paola J.

Curr Opin Pediatr. 2013 Feb;25(1):23-30. doi: 10.1097/MOP.0b013e32835bf77e. Review.

PMID:
23274430
[PubMed - indexed for MEDLINE]
15.

Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.

Stobart K, Iorio A, Wu JK.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003429. Review. Update in: Cochrane Database Syst Rev. 2011;(9):CD003429.

PMID:
16625581
[PubMed - indexed for MEDLINE]
16.

Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.

Stobart K, Iorio A, Wu JK.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003429. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003429.

PMID:
15846666
[PubMed - indexed for MEDLINE]
17.

Blood products for hemophilia: past, present and future.

Giangrande PL.

BioDrugs. 2004;18(4):225-34. Review.

PMID:
15244500
[PubMed - indexed for MEDLINE]
18.

Gene therapy for hemophilia.

Chuah MK, Collen D, VandenDriessche T.

J Gene Med. 2001 Jan-Feb;3(1):3-20. Review.

PMID:
11269333
[PubMed - indexed for MEDLINE]
19.

Clotting factor concentrates given to prevent bleeding and bleeding-related complications in people with hemophilia A or B.

Iorio A, Marchesini E, Marcucci M, Stobart K, Chan AK.

Cochrane Database Syst Rev. 2011 Sep 7;(9):CD003429. doi: 10.1002/14651858.CD003429.pub4. Review.

PMID:
21901684
[PubMed - indexed for MEDLINE]
20.

Haemophilia B: current pharmacotherapy and future directions.

Franchini M, Frattini F, Crestani S, Bonfanti C.

Expert Opin Pharmacother. 2012 Oct;13(14):2053-63. doi: 10.1517/14656566.2012.721780. Epub 2012 Sep 4. Review.

PMID:
22946758
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk